Search Results

Emerging drugs for irritable bowel syndrome

Authors: Shekhar, Chander; Whorwell, Peter J

Source: Expert Opinion on Emerging Drugs, Volume 14, Number 4, December 2009 , pp. 673-685(13)

Publisher: Informa Healthcare

Anabolic-androgenic steroid dependence: an emerging disorder

Authors: Kanayama, Gen; Brower, Kirk J.; Wood, Ruth I.; Hudson, James I.; Pope Jr, Harrison G.

Source: Addiction, Volume 104, Number 12, December 2009 , pp. 1966-1978(13)

Publisher: Blackwell Publishing

Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?

Authors: Rubovitch, Vardit; Pick, Chaim G; Sarne, Yosef

Source: Addiction Biology, Volume 14, Number 4, October 2009 , pp. 438-446(9)

Publisher: Blackwell Publishing

Shadows across μ-Star? Constitutively active μ-opioid receptors revisited

Author: Connor, Mark

Source: British Journal of Pharmacology, Volume 156, Number 7, April 2009 , pp. 1041-1043(3)

Publisher: Blackwell Publishing

Benign neonatal sleep myoclonus in newborn infants of opioid dependent mothers

Authors: Held-Egli, Katrin; Rüegger, Christoph; Das-Kundu, Seema; Schmitt, Bernhard; Bucher, Hans Ulrich

Source: Acta Pædiatrica, Volume 98, Number 1, January 2009 , pp. 69-73(5)

Publisher: Blackwell Publishing

Butorphanol/remifentanil interaction: First report of an interaction, leading to opioid withdrawal syndrome: case report

Source: Reactions, Volume 1, Number 1208, 2008-06-28 , pp. 9-9(1)

Publisher: Adis International

Hydromorphone withdrawal: Opioid withdrawal syndrome following switch to alfentanil: case report

Source: Reactions, Volume 1, Number 1205, 2008-06-07 , pp. 15-15(1)

Publisher: Adis International

Evaluation of a transdermal buprenorphine formulation in opioid detoxification

Authors: Lanier, Ryan K.; Umbricht, Annie; Harrison, Joseph A.; Nuwayser, Elie S.; Bigelow, George E.

Source: Addiction, Volume 102, Number 10, October 2007 , pp. 1648-1656(9)

Publisher: Blackwell Publishing

Naloxone treatment in opioid addiction: the risks and benefits

Authors: van Dorp, Eveline LA; Yassen, Ashraf; Dahan, Albert

Source: Expert Opinion on Drug Safety, Volume 6, Number 2, March 2007 , pp. 125-132(8)

Publisher: Informa Healthcare

Severe withdrawal syndrome in three newborns subjected to continuous opioid infusion and seizure activity dependent on brain hypoxia - ischemia. A possible link

Authors: BACHIOCCO, VALERIA; LORENZINI, LAURA; BARONCINI, SIMONETTA

Source: Paediatric Anaesthesia, Volume 16, Number 10, October 2006 , pp. 1057-1062(6)

Publisher: Blackwell Publishing

Buprenorphine-Containing Treatments: Place in the Management of Opioid Addiction

Author: Robinson, Susan E.

Source: CNS Drugs, Volume 20, Number 9, 2006 , pp. 697-712(16)

Publisher: Adis International

Endocannabinoids and Drug Dependence

Authors: Parolaro, Daniela; Vigano, Daniela; Rubino, Tiziana

Source: Current Drug Targets-CNS & Neurological Disorders, Volume 4, Number 6, December 2005 , pp. 643-655(13)

Publisher: Bentham Science Publishers

Chronic Pain and Ultrarapid Opioid Detoxification

Authors: Alan D. Kaye; Ron E. Banister; Jason M. Hoover; Amir R. Baluch; Scott Jacobs; Rinoo V. Shah

Source: Pain Practice, Volume 5, Number 1, March 2005 , pp. 33-42(10)

Publisher: Blackwell Publishing

Management of opioid-induced bowel dysfunction in cancer patients

Authors: Tamayo, Antonio; Diaz-Zuluaga, Paola

Source: Supportive Care in Cancer, Volume 12, Number 9, September 2004 , pp. 613-618(6)

Publisher: Springer

Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats

Authors: Araki, Hiroaki; Kawakami, Ken-ya; Jin, Chunyu; Suemaru, Katsuya; Kitamura, Yoshihisa; Nagata, Mari; Futagami, Koujiro; Shibata, Kazuhiko; Kawasaki, Hiromu; Gomita, Yutaka

Source: Psychopharmacology, Volume 171, Number 4, February 2004 , pp. 398-404(7)

Publisher: Springer

Cellular Mechanisms Underlying Neuronal Excitability during Morphine Withdrawal in Physical Dependence: Lessons from the Magnocellular Oxytocin System

Authors: Colin H. Brown; John A. Russell

Source: Stress, Volume 7, Number 2, June, 2004 , pp. 97-107(11)

Publisher: Informa Healthcare

Evaluation of an injection depot formulation of buprenorphine: placebo comparison

Authors: Sigmon, Stacey C.; Wong, Conrad J.; Chausmer, Allison L.; Liebson, Ira A.; Bigelow, George E.

Source: Addiction, Volume 99, Number 11, November 2004 , pp. 1439-1449(11)

Publisher: Blackwell Publishing

The -Hydroxybutyrate Withdrawal Syndrome

Authors: Asim F. Tarabar; Lewis S. Nelson

Source: Toxicological Reviews, Volume 23, Number 1, 2004 , pp. 45-49(5)

Publisher: Adis International

Buprenorphine in pregnant opioid-dependent women: first results of a prospective study

Authors: Lacroix, I.; Berrebi, A.; Chaumerliac, C.; Lapeyre-Mestre, M.; Montastruc, J. L.; Damase-Michel, C.

Source: Addiction, Volume 99, Number 2, February 2004 , pp. 209-214(6)

Publisher: Blackwell Publishing

Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice

Authors: Castañé, Anna; Robledo, Patricia; Matifas, Audrey; Kieffer, Brigitte L.; Maldonado, Rafael

Source: European Journal of Neuroscience, Volume 17, Number 1, January 2003 , pp. 155-159(5)

Publisher: Blackwell Publishing